From RuntimeWire · RuntimeWire · · 40s
Undecimal Launches with $18M Seed Round
Undecimal Bio secures $18M seed funding for mRNA delivery platform.
In brief
Undecimal Bio secures $18M seed funding for mRNA delivery platform. Undecimal Bio raised $18 million in seed funding to develop its mRNA delivery platform for renovascular disease. Originally reported by RuntimeWire.
Undecimal Bio
Undecimal Bio announced an oversubscribed $18 million seed round to support DELiveri platform development and renovascular programs.
Erlich's mRNA Findings
Erlich's mouse mRNA repression results do not establish human delivery, safety, or therapeutic efficacy for renovascular disease.
Funding Details
The round was co-led by 4BIO Capital and IQ Capital with participation from Verve Ventures, Harel Tech, Entrée Capital, Kerna Ventures, and Saras Capital.
The key point
Undecimal Bio raised $18 million in seed funding to develop its mRNA delivery platform for renovascular disease.
